Citation Tools
PDFCurrent controversy
Do coronavirus vaccine challenge trials have a distinctive generalisability problem?
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Do coronavirus vaccine challenge trials have a distinctive generalisability problem?
Other content recommended for you
- COVID-19 controlled human infection studies: worries about local community impact and demands for local engagement
- Exploring the ethics of tuberculosis human challenge models
- Research ethics and public trust in vaccines: the case of COVID-19 challenge trials
- Comparison of T-cell immune responses to SARS-CoV-2 spike (S) and nucleocapsid (N) protein using an in-house flow-cytometric assay in laboratory employees with and without previously confirmed COVID-19 in South Africa: nationwide cross-sectional study
- T cell immune memory after covid-19 and vaccination
- Research opportunities for the primordial prevention of rheumatic fever and rheumatic heart disease—streptococcal vaccine development: a national heart, lung and blood institute workshop report
- Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy
- Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccination
- Vaccine ethics: an ethical framework for global distribution of COVID-19 vaccines
- Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia